On Tuesday, Express Scripts released its annual list of formulary exclusions, which included several drugs to treat rare diseases like hemophilia, HIV and hepatitis C. Many of these products, ...

The digital health market continues to grow exponentially with apps that promote fitness, wellness and the prevention of chronic conditions as well as telehealth solutions and remote monitoring tools.

About eight month after its unveiling, Express Scripts has now revealed the companies and programs it is including in the inaugural cohort of its digital health formulary — the first such resource ...

(Reuters) - Express Scripts Holding Co on Tuesday announced a new drug reimbursement list with lower U.S. prices for brand-name medications, as a way to encourage drugmakers to move away from paying ...

Pharmacy benefit manager Express Scripts ESRX announced that it will include two new cholesterol-lowering drugs - Regeneron/Sanofi's REGN / SNY Praluent and Amgen's AMGN Repatha - on its National ...

Pharmacy benefit manager Express Scripts announced Dec. 12 the creation of a formulary to increase provider trust in and patient access to digital and mobile health apps and devices, including those ...

Another major pharmacy benefit manager is adding Humira biosimilars to its formulary beginning next year. Express Scripts, which is part of Cigna's Evernorth subsidiary, said Monday that it will add ...

BOSTON, Dec. 12, 2019 /PRNewswire/ -- SilverCloud Health, one of the leading digital mental health platforms, today announced that Express Scripts, the largest independent manager of pharmacy benefits ...

Express Scripts unveiled the details of its first digital health formulary on Thursday. The program, first announced by Cigna’s pharmacy benefit manager in May, gives the bustling field of health apps ...

Pharmacy benefit manager Express Scripts is launching a digital health formulary next year: a list of digital health tools, including smartphone apps and software-enabled medical devices, to help ...

Express Scripts will include Cyltezo and both Sandoz products (Hyrimoz and unbranded adalimumab-adaz) – inflammatory disease biosimilars with competitive net costs – as preferred products on the ...

Although the shift by big companies into private health exchanges has impacted negatively on PBMs such as Express Scripts, leading players in the industry continue to do well. Express Scripts has for ...